Trial Information

Summary: Rheumatoid Arthritis Study CAIN457A2101

The purpose of this clinical research study is to evaluate which dose level of the investigational drug is most effective in participants with rheumatoid arthritis. Participants will be given either study medicine or a placebo in a random fashion (like flipping a coin). The investigational drug being tested in this study is currently not on the market (available for you to buy) in any country. This is a phase 1 study which means that this is the first time that the study drug will be studied in humans.

Participants will be asked to come to the study center 16 times over a 16 week period. Each visit will require a stay of at least 48 hours, one day before dosing and one day after dosing.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 22, 2008 at 2:59:51 PM